NCT03923400View on ClinicalTrials.gov

Jejunoileal vs Gastric GIST in the Era of Imatinib.

CompletedOBSERVATIONAL
Enrollment

77

Participants

Timeline

Start Date

November 1, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Disease-free SurvivalOverall SurvivalRecurrence
Trial Locations (1)

30120

David Ferreras, Murcia

All Listed Sponsors
lead

Hospital Universitario Virgen de la Arrixaca

OTHER

NCT03923400 - Jejunoileal vs Gastric GIST in the Era of Imatinib. | Biotech Hunter | Biotech Hunter